- Report
- August 2023
- 270 Pages
Global
From €2341EUR$2,450USD£1,992GBP
- Report
- December 2023
- 149 Pages
Global
From €4730EUR$4,950USD£4,025GBP
- Report
- March 2024
Global
From €4635EUR$4,850USD£3,944GBP
- Report
- February 2024
- 137 Pages
Global
From €4730EUR$4,950USD£4,025GBP
- Report
- December 2023
Global
From €4730EUR$4,950USD£4,025GBP
- Report
- November 2023
- 88 Pages
Global
From €1625EUR$1,700USD£1,382GBP
€1911EUR$2,000USD£1,626GBP
- Report
- October 2023
- 470 Pages
Global
From €2274EUR$2,380USD£1,935GBP
€2676EUR$2,800USD£2,277GBP
- Report
- August 2023
- 58 Pages
Global
€1823EUR$1,975USD£1,499GBP
- Report
- March 2024
- 132 Pages
Global
From €5256EUR$5,500USD£4,472GBP
- Report
- February 2024
- 158 Pages
Global
From €5256EUR$5,500USD£4,472GBP
- Report
- November 2023
- 67 Pages
Global
From €3345EUR$3,500USD£2,846GBP
- Report
- November 2023
- 120 Pages
Global
From €5256EUR$5,500USD£4,472GBP
- Report
- January 2024
- 485 Pages
Global
From €5256EUR$5,500USD£4,472GBP
- Report
- November 2023
- 171 Pages
Global
From €5256EUR$5,500USD£4,472GBP
- Report
- October 2023
- 186 Pages
Global
From €5256EUR$5,500USD£4,472GBP
- Report
- October 2023
- 157 Pages
Global
From €5256EUR$5,500USD£4,472GBP
- Report
- September 2023
- 180 Pages
Global
From €5256EUR$5,500USD£4,472GBP
- Report
- August 2023
- 336 Pages
Global
From €5256EUR$5,500USD£4,472GBP
- Report
- July 2023
Global
From €3345EUR$3,500USD£2,846GBP
- Report
- September 2023
- 135 Pages
Global
From €4300EUR$4,500USD£3,659GBP
The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more